 |
 |
PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using proprietary Medisperse™ nanoparticle and other formulation technologies and our value adding IP++™ process.
We address areas of significant unmet medical need and value to patients on a global basis. PharmaNova’s current focus is on extraordinary value products in Women’s Health and adjacent areas, including a non-hormonal treatment for menopausal hot flashes, anti-viral agents and cancer chemotherapeutics.
Our portfolio includes low risk, fast-to-market products and licensing opportunities for commercialization partners worldwide.
|
|
|
|
Recent News
Monday, June 09, 2008
PharmaNova to exhibit at Bio-2008: San Diego Convention Center – June 17-20, 2008.
PharmaNova Inc. will be exhibiting in the NY State Bio Pavilion at the 2008 Bio International Conference and Exhibition to be held at the San Diego Convention Center June 17-20. The NYS pavi...
Friday, January 25, 2008
Rochester, NY, January 25th. 2008: PharmaNova, Inc. Appoints Deepak Thassu as Vice-President, Pharmaceutical Development.
Press release: Rochester, NY, January 25th. 2008. PharmaNova, Inc. Appoints Deepak Thassu as Vice-President, Pharmaceutical Development.
PharmaNova Inc. announced today that it has h...
Friday, August 17, 2007
PharmaNova to present at UK conference, BioPartnering Europe 2007.
Rochester, New York: August 17, 2007.
PharmaNova Inc. announced today that the company will be presenting at the 15th anniversary meeting of BioPartnering Europe (http://ww...
Wednesday, August 15, 2007
Rochester, NY: PharmaNova partners with diagnostics and device company, Rochester Innovations
PharmaNova Inc. announced today that it has entered into a collaboration with Rochester Innovations Inc., a specialty diagnostics and devices company of Rochester, NY.
The co...
Thursday, March 29, 2007
PharmaNova expands into new lab. facilities to accelerate its nanoparticle R&D. See "Contact us" for new address.
...
Friday, March 16, 2007
PharmaNova forms Strategic Alliance with Taiwan based Orient Europharma
PharmaNova Inc., announced today that it has formed a strategic alliance and collaboration with Orient Europharma Company Ltd. (OEP) of Taiwan, R.O.C. In this 2-way relationship, it is ...
Monday, March 12, 2007
PHARMANOVA'S LICENSEE DEPOMED FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR GABAPENTIN GR FOR THE TREATMENT OF POSTMENOPAUSAL HOT FLASHES
MENLO PARK, Calif., Mar 12, 2007 (BUSINESS WIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced today that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Dru...
Thursday, March 08, 2007
PHARMANOVA GRANTS EXCLUSIVE U.S. LICENSE TO DEPOMED FOR EXTENDED RELEASE GABAPENTIN USE IN HOT FLASHES
Rochester, New York, October 18, 2006 – PharmaNova, Inc. announced today that it has exclusively licensed certain U.S. patent rights to Depomed Inc. to develop and commercialize an ext...
|
|
 |
